Navigation Links
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent
Date:3/17/2010

WATERLOO, Belgium, March 17, 2010 /PRNewswire/ --

- SORT OUT III Data Presented at American College of Cardiology Meeting in Atlanta and Published in the Lancet

Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet. The CYPHER(R) Stent was associated with significantly lower rates of death, myocardial infarction (heart attack), and repeat revascularization (the need for another procedure) than the Endeavor(R) Stent out to 18 months. This study adds to the unmatched body of safety and efficacy data on the CYPHER(R) Stent with this comparison to the more recently approved Endeavor(R) Stent in a contemporary setting.

The large randomized trial SORT OUT III included more than 2,300 patients across a wide range of lesion and patient complexity. The investigators reported that the mortality rate (4.4% for Endeavor(R) vs. 2.7% for CYPHER(
'/>"/>

SOURCE Cordis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
2. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
3. INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
4. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
5. Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
6. Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease
7. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
8. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
9. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
10. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
11. Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com ... available in its catalogue: North America ... http://www.reportlinker.com/p02343464/North-America-Laparoscopes-Market-Outlook-to-2020.html North America Laparoscopes ... new report, "North America Laparoscopes Market Outlook to ... America Laparoscopes market. The report provides value, in ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- EDGE ... device space, is excited to announce they have ... VIEW Plating System and REDUCE Fracture Plating System. ... plates used to support multiple indications within the ... Lapidus, First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular (TN) ...
(Date:8/28/2014)... , Aug. 28, 2014  Decision Resources Group finds that ... at around $7.7 billion by 2023 in the ... Germany , Italy , ... and Japan . The biosimilar erosion ... be balanced out by the launch of Eli Lilly,s Cyramza, ...
Breaking Medicine Technology:North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11EDGE Orthopaedics Receives Second FDA Clearance 2The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2
... DUBLIN, October 30 Shire plc (LSE: SHP, NASDAQ:,SHPGY) the global specialty biopharmaceutical company, announces results for,the three months to September ... ... Q3 2009(1), Product sales ... million -15%, Product sales from core products(2) ...
... TAIPEI, Taiwan, Oct. 30 ... in Beijing: from bench to bedside and community, ... This solution entails a series of,innovative professional ... diagnosis, and treatment follow-up. Microlife successfully,developed several ...
Cached Medicine Technology:Shire Continues to Deliver Excellent Growth From Core Products 2Shire Continues to Deliver Excellent Growth From Core Products 3Shire Continues to Deliver Excellent Growth From Core Products 4Shire Continues to Deliver Excellent Growth From Core Products 5Shire Continues to Deliver Excellent Growth From Core Products 6Shire Continues to Deliver Excellent Growth From Core Products 7Shire Continues to Deliver Excellent Growth From Core Products 8Shire Continues to Deliver Excellent Growth From Core Products 9Shire Continues to Deliver Excellent Growth From Core Products 10Shire Continues to Deliver Excellent Growth From Core Products 11Shire Continues to Deliver Excellent Growth From Core Products 12Shire Continues to Deliver Excellent Growth From Core Products 13Shire Continues to Deliver Excellent Growth From Core Products 14Shire Continues to Deliver Excellent Growth From Core Products 15Shire Continues to Deliver Excellent Growth From Core Products 16Shire Continues to Deliver Excellent Growth From Core Products 17Shire Continues to Deliver Excellent Growth From Core Products 18Shire Continues to Deliver Excellent Growth From Core Products 19Shire Continues to Deliver Excellent Growth From Core Products 20Shire Continues to Deliver Excellent Growth From Core Products 21Shire Continues to Deliver Excellent Growth From Core Products 22Shire Continues to Deliver Excellent Growth From Core Products 23Shire Continues to Deliver Excellent Growth From Core Products 24Shire Continues to Deliver Excellent Growth From Core Products 25Shire Continues to Deliver Excellent Growth From Core Products 26Shire Continues to Deliver Excellent Growth From Core Products 27Shire Continues to Deliver Excellent Growth From Core Products 28Shire Continues to Deliver Excellent Growth From Core Products 29Shire Continues to Deliver Excellent Growth From Core Products 30Shire Continues to Deliver Excellent Growth From Core Products 31Shire Continues to Deliver Excellent Growth From Core Products 32Shire Continues to Deliver Excellent Growth From Core Products 33Microlife-WatchBP Series is Proud to Present its Total Concept at the World Hypertension Congress 2Microlife-WatchBP Series is Proud to Present its Total Concept at the World Hypertension Congress 3
(Date:8/28/2014)... iFitDress.com, the distinguished wedding dress manufacturer and retailer, has ... . Included in the new range are hundreds of ... provided at deeply discounted prices, from 22 to 62 ... reliable delivery service. All clients from around the world ... As is commonly noted, international customers have different needs ...
(Date:8/28/2014)... Blood's Thicker Than Water is based on a ... in the heart of the city. Raymond E. Blake paints ... how disrespect caused two families to collide with each other ... Yayo Boyz and the M.O.B. Boyz clash in a rain ... in a silent terror. "Guerrilla," AKA "Real," runs his Mob ...
(Date:8/28/2014)... 28, 2014 Millennium Treatment Group has ... in the workplace. A recent report from the ... states that drug abuse is costing employers an estimated ... are addicted to drugs affect their employers and the ... into the workplace, causing expensive problems for their employers, ...
(Date:8/28/2014)... plans its exit strategy from the war, now may be ... health care to veterans, says a Perspective piece in the ... go on doing more of the same is to fail ... and population structure pose in the longer run," said William ... Practice, and David Auerbach, from the RAND Corporation, in the ...
(Date:8/28/2014)... 2014 The Governor of Yucatán, Rolando ... at a press conference; this event is organized by ... of Economy through the National Microenterprise Financing Program ( ... to the 5th at the Convention Center Yucatan Siglo ... a great responsibility for Yucatan to host the 17th ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Drug Use Causes Problems in the Workplace 2Health News:A VA exit strategy 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
... that early surgery for acute shoulder dislocation may provide ... approximately 45 million children and adolescents participate in organized ... Two types of shoulder injuries that occur in these ... care. According to a paper published in the February ...
... PASADENA, Calif., Feb. 2 Alexandria Real Estate Equities, Inc. ... conduct a conference call and audio web cast on Monday, ... conjunction with the release of its operating and financial results ... Alexandria anticipates releasing its operating and financial results before ...
... 2 Pet advocates are encouraging,pet owners to focus ... Pet,Dental Health Month this February. And it appears ... PetFirst Healthcare saw claims,for illnesses related to oral-health increase ... "Many pet owners don,t place as much emphasis ...
... gather for the Experimental Biology 2009 meeting at the ... 18 -April 22. , Experimental Biology,s mission is to ... future and current clinical advances and to give ... colleagues working on similar biomedical problems using different disciplines. ...
... Feb. 2 Availity, LLC, a leading ... MedEZ, a leading,provider of medical and behavioral ... health care claim transactions. Health care,providers with ... via the,Availity(R) Health Information Network. The partnership ...
... 2 WHAT: The new Health Workforce Information ... to the most recent resources on the nation,s ... shortages of physicians, nurses and allied health personnel ... help policy makers, hospitals and schools develop strategies ...
Cached Medicine News:Health News:Immediate Orthopaedic Care Can Help Heal a Young Athlete's Shoulder 2Health News:Immediate Orthopaedic Care Can Help Heal a Young Athlete's Shoulder 3Health News:Pet Dental Claims Skyrocket 2Health News:Experimental Biology 2009 meets April 18-22 2Health News:Experimental Biology 2009 meets April 18-22 3Health News:Experimental Biology 2009 meets April 18-22 4Health News:Experimental Biology 2009 meets April 18-22 5Health News:Availity Partners With MedEZ 2Health News:Press Conference Invitation: Health Workforce Information Center (HWIC) Launch 2
Angled insertion forcep used for the Hydroview lens. Manufactured in titanium....
Bi-angled insertion jaws designed to enhance surgeon comfort and efficiency. Reverse action releases lens when handle is compressed. Made in titanium....
Biconvex jaw design. 40 degree angled shafts. Tip to angle length: 7.5 mm. Locking handle. Manufacturing in titanium....
Titanium. Forceps designed for insertion of Hydroview foldable intraocular lenses. Unique cross-action design allows for easy insertion of most foldable lens styles....
Medicine Products: